June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
The epithelial basement membrane component perlecan is produced by stromal cells in vitro
Author Affiliations & Notes
  • Abirami Santhanam
    Ophthalmology, Cleveland clinic foundation, Shaker heights, OH
  • Andre Torricelli
    University of Sao Paulo, Sao Paulo, Brazil
  • Jiahui Wu
    Ophthalmology, Cleveland clinic foundation, Shaker heights, OH
  • Steven E Wilson
    Ophthalmology, Cleveland clinic foundation, Shaker heights, OH
  • Footnotes
    Commercial Relationships Abirami Santhanam, None; Andre Torricelli, None; Jiahui Wu, None; Steven Wilson, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4902. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Abirami Santhanam, Andre Torricelli, Jiahui Wu, Steven E Wilson, ; The epithelial basement membrane component perlecan is produced by stromal cells in vitro. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4902.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To investigate the production of the corneal epithelial basement membrane (BM) component perlecan by cultured stromal cells.

 
Methods
 

Keratocytes were isolated from fresh rabbit corneal stroma treated with hyaluronidase and collagenase for 24 hours. Keratocytes were then grown in different serum conditions 1%, 5% and 10% FBS with or without the growth factors FGF-2 (40ng/ml) and heparin sulfate (HS) (5ug/ml) or TGF-β (2ng/ml) for 60-72 hours. Different culture condition effects were analyzed by real time PCR, immunostaining and western blots for the cell specific markers keratocan, lumican and alpha-smooth muscle actin (SMA). Perlecan mRNA synthesis was analyzed by QPCR and protein production by western blotting, immunostaining and ELISA.

 
Results
 

Keratocytes grown in serum-free medium expressed high levels of keratocan and lumican (keratocan+, lumican+ and SMA-) while those grown in 10% FBS with FGF-2 expressed low levels and were corneal fibroblasts (keratocan- lumican- and SMA-). As the serum concentration increased, the cultured cells became less keratocyte and more corneal fibroblast in phenotype. Analysis of α-SMA revealed that cells grown in 1% FBS with TGF-β expressed high levels of α-SMA and were myofibroblasts (keratocan- lumican- and SMA+). Keratocytes produced more perlecan protein than corneal fibroblasts or myofibroblasts (Fig.1).

 
Conclusions
 

Keratocytes grown in vitro produce perlecan that likely contributes to epithelial basement membrane regeneration in vivo. Corneal fibroblasts and myofibroblasts also produce perlecan, albeit at lower levels than keratocytes.  

 
Figure 1. Perlecan immunostaining under different culture conditions. Keratocytes produce more perlecan protein (red) compared to corneal fibroblasts and myofibroblasts. Blue is DAPI staining of cell nuclei. Magnification 400x.
 
Figure 1. Perlecan immunostaining under different culture conditions. Keratocytes produce more perlecan protein (red) compared to corneal fibroblasts and myofibroblasts. Blue is DAPI staining of cell nuclei. Magnification 400x.

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×